CMX Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Oakville ON Canada (1992)

Organization Overview

First Clinical Trial
2007
NCT00426777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CMX Research

Active Ingredients

Drugs in Phase 3 Trials (1)

risedronate (actonel) (1 trial)

Drugs in Phase 2 Trials (2)

2-hydroxyflutamide (1 trial)

orca-010 (1 trial)

Drugs in Phase 1 Trials (1)

goserelin (zoladex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4